LNP 1892Alternative Names: LNP1892
Latest Information Update: 06 Apr 2016
At a glance
- Originator Lupin
- Mechanism of Action Calcium-sensing receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Hyperparathyroidism
Most Recent Events
- 06 Apr 2016 Phase-I development is ongoing in United Kingdom